Home Repairon Immuno GmbH

Repairon Immuno GmbH

Repairon Immuno GmbH

Repairon Immuno GmbH
Category
Business Description
Repairon Immuno GmbH is a young startup with a mission to develop novel cell therapies to treat most challenging diseases. To achieve this goal, we will take advantage of exclusively licensed induced Pluripotent Stem Cell (iPSC) line, which is the only iPSC line being currently validated in European clinical trial. This cell line in combination with our proprietary, scalable, GMP-compliant differentiation platform as well as proprietary gene editing designs will enable us to generate never-done-before types of cell drug products. Moreover, using iPSCs as an initial cell source will allow to dramatically simplify manufacturing and significantly reduce therapy costs. Consequently, lower prices will enable treatment of previously overlooked indications, such as (rare) autoimmune disorders and less frequent cancers (e.g., T cell malignancies). We believe that with our products we will address unmet medical needs of patients.
Based in
Munich
Tags
iPSC, cell therapy, CAR cells, autoimmune diseases
Total Funding
Between €100K-€500K
Founded
2019
Website
https://de.linkedin.com/company/repairon-immuno
Company Status
Active
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Repairon Immuno GmbH? We're happy to assist you with our Startup Sourcing service.